ATLANTA, Aug. 31 /PRNewswire/ -- Goodroe Healthcare Solutions, LLC, announces July utilization of coronary stent devices. For the month of July, the J&J Cypher stent gained additional market share utilization from Boston Scientific's Taxus stent. The overall utilization of drug eluting stents for all stent cases remained stable at 78.77%. Utilization trends for the past four months:
April May June July J&J Cypher 34.22% 41.75% 43.66% 48.2% Boston Scientific Taxus 65.78% 58.25% 56.34% 51.8%
The changes in utilization market share coincide with recent recalls of some of the Taxus product.
Goodroe Healthcare Solutions, LLC is a healthcare firm that provides hospitals and physicians with comprehensive solutions to address opportunities for market growth, cost reduction, quality improvement and revenue enhancement. Containing more than 1,000,000 cath lab and open heart surgery procedures, the Goodroe Data Warehouse is the most comprehensive database of cardiovascular/cardiothoracic devices, medications, outcomes, cost and productivity available.
For further information, please send an email to ghs@goodroe.com.
Goodroe Healthcare Solutions, LLCCONTACT: Pierson Gerritsen, +1-770-938-9686, for Goodroe HealthcareSolutions, LLC
Web site: http://www.goodroe.com/